A Study to Determine the Preferred Dose of Lisinopril for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
EARLY_PHASE1
30
about 3.9 years
18–70
Male only
1 site in NY
What this study is about
This trial is testing a treatment called lisinopril to see if it can prevent urinary problems in men with prostate cancer who are receiving radiation therapy. The goal is to find the best dose of lisinopril and understand how it affects urine symptoms, biomarkers, and their connection to those symptoms.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Lisinopril Tablets
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
lisinopril (ACE inhibitor; blocks angiotensin-converting enzyme to lower blood pressure)
oral (Oral Tablet)
Oncology